A gentler approach to monitor for heart transplant rejection
Frontiers in Cardiovascular Medicine
FEBRUARY 5, 2024
Despite developments in circulating biomarker and imaging technology in the assessment of cardiovascular disease, the surveillance and diagnosis of heart transplant rejection has continued to rely on histopathologic interpretation of the endomyocardial biopsy.
Let's personalize your content